Tumor location as a novel high risk parameter for stage II colorectal cancers
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor location as a novel high risk parameter for stage II colorectal cancers
Authors
Keywords
Colorectal cancer, Cancer detection and diagnosis, Rectal cancer, Histology, Lymph nodes, Survival analysis, Adjuvant chemotherapy, Prognosis
Journal
PLoS One
Volume 12, Issue 6, Pages e0179910
Publisher
Public Library of Science (PLoS)
Online
2017-06-24
DOI
10.1371/journal.pone.0179910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients
- (2016) Jiao Yang et al. PLoS One
- Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
- (2015) Andreas Teufel et al. BMC CANCER
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades
- (2015) Fischer Joern et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According toBRAFMutation and Mismatch Repair Status of the MOSAIC Study
- (2015) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
- (2014) D. Klingbiel et al. ANNALS OF ONCOLOGY
- Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
- (2014) E. Missiaglia et al. ANNALS OF ONCOLOGY
- Elevation of Preoperative s-CEA Concentration in Stage IIA Colorectal Cancer Can Also Be a High Risk Factor for Stage II Patients
- (2013) Chan Wook Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
- (2013) Dora Colussi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Secular Trends in Colon and Rectal Cancer Relative Survival
- (2013) C. M. Rutter et al. JNCI-Journal of the National Cancer Institute
- Differences in Survival between Colon and Rectal Cancer from SEER Data
- (2013) Yen-Chien Lee et al. PLoS One
- Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
- (2012) Tomoya Yokota Anti-Cancer Agents in Medicinal Chemistry
- Colorectal cancer: a tale of two sides or a continuum?: Figure 1
- (2012) Mai Yamauchi et al. GUT
- Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
- (2012) Amanda K. Arrington et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival
- (2011) Frank Benedix et al. DISEASES OF THE COLON & RECTUM
- Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803
- (2011) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data
- (2011) Jennifer M. Weiss et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
- (2010) Barbara Leggett et al. GASTROENTEROLOGY
- Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles
- (2010) Minoo INTERNATIONAL JOURNAL OF ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer
- (2010) Frank A. Sinicrope Nature Reviews Clinical Oncology
- Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
- (2010) Sun Lee et al. PATHOLOGY INTERNATIONAL
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers?
- (2008) Robert A. Meguid et al. ANNALS OF SURGICAL ONCOLOGY
- Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy
- (2008) Hak-Mien Quah et al. DISEASES OF THE COLON & RECTUM
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology
- (2007) Toru Nawa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started